SCHEMBL4884638

SCHEMBL4884638

CC[C@@](N)(CCCN)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ODC1 P11926 2/20 0.64
ARG2 P78540 11/20 0.61
ARG1 P05089 10/20 0.61
MEN1 O00255 1/20 0.61
ALDH1A1 P00352 1/20 0.61
CYP1A2 P05177 1/20 0.61
THRB P10828 1/20 0.61
KMT2A Q03164 1/20 0.61
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
RAB9A P51151 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4884641 1.00 ODC1 (0.64) ODC1ARG2ARG1MEN1ALDH1A1
SCHEMBL4884643 1.00 ODC1 (0.64) ODC1ARG2ARG1MEN1ALDH1A1
SCHEMBL7198295 0.94 ARG2 (0.65) ODC1ARG2ARG1MEN1ALDH1A1
SCHEMBL2471683 0.94 ARG2 (0.65) ODC1ARG2ARG1MEN1ALDH1A1
SCHEMBL5322729 0.92 ARG2 (0.62) ODC1ARG2ARG1MEN1ALDH1A1
SCHEMBL5320097 0.92 ARG2 (0.62) ODC1ARG2ARG1MEN1ALDH1A1
SCHEMBL5324175 0.86 MEN1 (0.65) ODC1ARG2ARG1MEN1ALDH1A1
SCHEMBL11267854 0.85 ODC1 (0.62) ODC1ARG2ARG1MEN1ALDH1A1
SCHEMBL11267850 0.85 ODC1 (0.62) ODC1ARG2ARG1MEN1ALDH1A1
SCHEMBL8533012 0.85 ODC1 (0.62) ODC1ARG2ARG1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8591874-B2 Inhibition of mammalian hair growth THE PROCTER & GAMBLE COMPANY (US) 2013-11-26 US disclosed
US-8481015-B2 Applying agmatine and a dermatologically acceptable carrier to the skin; inhibiting hair growth THE PROCTER & GAMBLE COMPANY (US) 2013-07-09 US disclosed
US-7432302-B2 Composition containing polyamine transport inhibitor and use thereof MEDIQUEST THERAPEUTICS, INC. (US) 2008-10-07 US disclosed
US-20080188505-A1 Regulation of Mammalian Hair Growth OBLONG JOHN ERICH 2008-08-07 US disclosed
US-20080057015-A1 Hair care compositions, methods, and articles of commerce that can help maintain a longer lasting hair style appearance THE PROCTER & GAMBLE COMPANY 2008-03-06 US disclosed
US-20070203240-A1 Personal care compositions and methods for regulating mammalian hair growth THE PROCTER & GAMBLE COMPANY 2007-08-30 US disclosed
EP-1750655-A1 PERSONAL CARE COMPOSITIONS AND METHODS FOR REGULATING MAMMALIAN HAIR GROWTH AND SKIN CONDITION The Procter and Gamble Company (US) 2007-02-14 EP disclosed
US-20060127431-A1 Regulation of mammalian hair growth THE PROCTER & GAMBLE COMPANY 2006-06-15 US disclosed
EP-1601340-A2 REGULATION OF MAMMALIAN HAIR GROWTH THE PROCTER & GAMBLE COMPANY (US) 2005-12-07 EP disclosed
WO-2005110353-A1 PERSONAL CARE COMPOSITIONS AND METHODS FOR REGULATING MAMMALIAN HAIR GROWTH AND SKIN CONDITION THE PROCTER & GAMBLE COMPANY (US) 2005-11-24 WO disclosed
US-20050255060-A1 Personal care compositions and methods regulating mammalian hair growth PROCTER & GAMBLE COMPANY, THE 2005-11-17 US disclosed
US-20050255059-A1 Personal care compositions and methods regulating mammalian hair growth PROCTER & GAMBLE COMPANY, THE 2005-11-17 US disclosed
US-20050245615-A1 Composition containing polyamine transport inhibitor and use thereof MEDIQUEST THERAPEUTICS, INC. (US) 2005-11-03 US disclosed
US-20050003024-A1 Regulation of mammalian hair growth THE PROCTER & GAMBLE COMPANY 2005-01-06 US disclosed
WO-2004078157-A2 REGULATION OF MAMMALIAN HAIR GROWTH THE PROCTER & GAMBLE COMPANY (US) 2004-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050255059-A1 Personal care compositions and methods regulating mammalian hair growth PLOD3, MITF, AADAT ODC1 2732/4885ARG2 1235/4885ARG1 1468/4885
US-20060127431-A1 Regulation of mammalian hair growth BHMT, UGCG, HNMT ODC1 689/4885ARG2 1044/4885ARG1 1496/4885
US-20080188505-A1 Regulation of Mammalian Hair Growth BHMT, UGCG, HNMT ODC1 689/4885ARG2 1044/4885ARG1 1496/4885
US-20050245615-A1 Composition containing polyamine transport inhibitor and use thereof SLC7A1, SRM, SLC16A1 ODC1 15/4885ARG2 108/4885ARG1 43/4885
US-20050255060-A1 Personal care compositions and methods regulating mammalian hair growth PCMT1, PLOD3, ARNT ODC1 3000/4885ARG2 1364/4885ARG1 1914/4885
US-20050003024-A1 Regulation of mammalian hair growth BHMT, UGCG, HNMT ODC1 689/4885ARG2 1044/4885ARG1 1496/4885
US-20070203240-A1 Personal care compositions and methods for regulating mammalian hair growth PLOD1, PLOD3, PLOD2 ODC1 242/4885ARG2 747/4885ARG1 998/4885
US-20080057015-A1 Hair care compositions, methods, and articles of commerce that can help maintain a longer lasting hair style appearance SHH, CAPRIN1, CUTA ODC1 1974/4885ARG2 2308/4885ARG1 994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.